Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05129345 · ClinicalTrials.gov registry record

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

A clinical trial of Hypertension and Type 2 Diabetes, sponsored by Duke University.

Recruiting
Registry status
150
Enrollment target
2
Study locations

NCT05129345 is a study of Hypertension and Type 2 Diabetes that is actively recruiting participants, run by Duke University. The registered enrollment target is 150 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05129345, a study of Hypertension and Type 2 Diabetes, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
150 participants
Enrollment target
2
Study locations

Study Summary

This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders. Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatment goals for cardiometabolic disorders in PLWH at the study sites.

Conditions Studied

Hypertension Type 2 Diabetes HIV-1-infection Dyslipidemias

Study Locations (2)

North Carolina

  • Duke University - Charlotte Study Sites - Charlotte
  • Duke University - Duke Study Site - Durham

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-06-07
Est. Completion 2026-12-31

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05129345

The ClinicalTrials.gov registry entry for NCT05129345 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT05129345 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05129345 about?

NCT05129345 is a clinical study titled "Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US". This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders. Aim 3: Tailor a self-manageme...

What is the current status of trial NCT05129345?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2022-06-07. Estimated completion is 2026-12-31.

What conditions does trial NCT05129345 study?

This clinical trial studies the following conditions: Hypertension, Type 2 Diabetes, HIV-1-infection, Dyslipidemias.

Who is sponsoring clinical trial NCT05129345?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05129345 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Type 2 Diabetes

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.